Seattle's 'other' tech sector, life science, is on the upswing again
In a quiet business park far from Seattle's booming South Lake Union, players in the Northwest's "other" tech sector are coping with growing pains of their own.
In a quiet business park far from Seattle's booming South Lake Union, players in the Northwest's "other" tech sector are coping with growing pains of their own.
Business
Jan 31, 2019
0
6
(Phys.org) —A team of researchers working at the Sloan Kettering Institute for Cancer Research has succeeded in building a glycoprotein from scratch. It marks an enormous step forward, the team reports in their paper published ...
Russian scientists claimed Wednesday they have discovered blood in the carcass of a woolly mammoth, adding that the rare find could boost their chances of cloning the prehistoric animal.
Archaeology
May 29, 2013
39
0
Female professors are almost 50 percent less likely than their male counterparts to be invited to join corporate scientific advisory boards (SABs) and start new companies mainly because of gender stereotyping, says University ...
Social Sciences
Mar 12, 2013
0
0
A nanotech material containing an extract from liquorice can be used to sterilize and protect medical devices and implants which include biological components, and protects these functional bio-components during the sterilization ...
Nanomaterials
Oct 8, 2012
0
0
Cuba has unveiled its first manufactured nanopharmaceutical drug—a tweaked variety of cyclosporine, used to help prevent transplant rejection—official media reported Saturday.
Bio & Medicine
Sep 23, 2012
1
0
(AP) -- The Vatican has entered into an unusual partnership with a small U.S. biotech company to promote using adult stem cells for treating disease, rather than focusing research on embryonic stem cells.
Other
Nov 9, 2011
0
0
A US biotech company said Thursday it will soon begin the first-ever European trials using human embryonic stem cells in an experimental treatment for people with a form of juvenile blindness.
Biotechnology
Sep 22, 2011
0
0
Disgraced South Korean scientist Hwang Woo-Suk has won a copyright battle over dog-cloning techniques his colleagues said Saturday.
Biotechnology
Sep 19, 2009
0
0